Covered recipient · General Payments record
HARVEY W BOWLES
Allopathic & Osteopathic Physicians Internal Medicine
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
Saved only in this browser. No account or alerts.
General Payments · PY2020 · Entire year
$2,062.12
118 records · 0 disputed
“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”
— Centers for Medicare & Medicaid Services, Open Payments
A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.
These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Methodology & Data — sourcing, labeling, and limitations.
Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗
By nature of payment
PY2020 · entire year · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,962.13 | 117 |
| Education | $99.99 | 1 |
By paying entity
PY2020 · entire year · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk Inc | $543.36 | 34 |
| GlaxoSmithKline, LLC. | $302.33 | 14 |
| Amarin Pharma Inc. | $200.87 | 13 |
| AstraZeneca Pharmaceuticals LP | $169.55 | 9 |
| Lilly USA, LLC | $152.48 | 11 |
| SANOFI-AVENTIS U.S. LLC | $140.78 | 8 |
| Astellas Pharma US Inc | $122.10 | 2 |
| Amgen Inc. | $86.46 | 6 |
| Merck Sharp & Dohme Corporation | $69.24 | 4 |
| Esperion Therapeutics, Inc. | $42.11 | 2 |
| Eisai Inc. | $42.05 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $34.38 | 2 |
| PFIZER INC. | $30.91 | 2 |
| Abbott Laboratories | $26.21 | 1 |
| Arbor Pharmaceuticals, Inc. | $15.34 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.23 | 1 |
| Avion Pharmaceuticals | $15.16 | 1 |
| Horizon Therapeutics plc | $13.96 | 1 |
| Zyla Life Sciences, Inc. | $13.45 | 1 |
| Alexion Pharmaceuticals, Inc. | $13.32 | 1 |
| Kowa Pharmaceuticals America, Inc. | $12.83 | 1 |
Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.
IndustryPayments · General Payments
HARVEY W BOWLES
NPI 1285723718 · CMS profile ID 285362
Allopathic & Osteopathic Physicians / Internal Medicine
NASHVILLE, TN
A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.
A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.
General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types
Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00
Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export.
Filtered page: https://industrypayments.org/provider/npi-1285723718?year=2020&recipient=provider&page=2#records-h
CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019
Cite these filtered records
The citation includes this program year, filters, data edition, and page of results.
- Plain
- HARVEY W BOWLES, NPI 1285723718, CMS profile ID 285362. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1285723718?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
- APA 7
- IndustryPayments. (2026). HARVEY W BOWLES, NPI 1285723718, CMS profile ID 285362. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1285723718?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
- Bluebook
- HARVEY W BOWLES, NPI 1285723718, CMS profile ID 285362, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1285723718?year=2020&recipient=provider&page=2#records-h.
Centers for Medicare & Medicaid Services, Open Payments
Citation formats are provided for reference; check the requirements of your publication.
Payment records · PY2020
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30
118 matching records · $2,062.12 reported total · 0 disputed
Nature of payment: All payment types
Records imported here (UTC).
CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.
Showing records 51–100 of 118.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Publication flags | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $26.21 | 08/23/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 749011659 | CMS |
| Lilly USA, LLC | $14.64 | 08/21/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 728449521 | CMS |
| Novo Nordisk Inc | $21.13 | 08/21/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744857341 | CMS |
| Avion Pharmaceuticals | $15.16 | 08/18/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 741999009 | CMS |
| SANOFI-AVENTIS U.S. LLC | $13.10 | 08/17/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744110921 | CMS |
| Novo Nordisk Inc | $18.94 | 08/13/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744832803 | CMS |
| Amgen Inc. | $13.82 | 08/11/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 741392519 | CMS |
| Amarin Pharma Inc. | $16.41 | 08/07/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 739896515 | CMS |
| SANOFI-AVENTIS U.S. LLC | $17.48 | 08/07/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744110915 | CMS |
| Lilly USA, LLC | $15.92 | 08/06/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 728456233 | CMS |
| Novo Nordisk Inc | $20.19 | 08/03/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744832588 | CMS |
| Merck Sharp & Dohme Corporation | $15.49 | 07/31/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 747678029 | CMS |
| Novo Nordisk Inc | $106.71 | 07/30/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744880165 | CMS |
| Novo Nordisk Inc | $14.80 | 07/28/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744795729 | CMS |
| Novo Nordisk Inc | $2.84 | 07/28/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744795731 | CMS |
| Amarin Pharma Inc. | $19.15 | 07/21/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 739899733 | CMS |
| Novo Nordisk Inc | $5.23 | 07/21/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744797175 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.19 | 07/15/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 736337837 | CMS |
| GlaxoSmithKline, LLC. | $13.33 | 07/14/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 738652433 | CMS |
| Eisai Inc. | $11.93 | 07/10/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 751209357 | CMS |
| GlaxoSmithKline, LLC. | $21.16 | 07/08/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 738830049 | CMS |
| Astellas Pharma US Inc | $22.11 | 07/07/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 718302635 | CMS |
| Novo Nordisk Inc | $10.52 | 07/06/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744789305 | CMS |
| Merck Sharp & Dohme Corporation | $18.37 | 06/26/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 747633579 | CMS |
| Lilly USA, LLC | $16.39 | 06/25/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 728442767 | CMS |
| Novo Nordisk Inc | $2.06 | 06/22/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744749465 | CMS |
| Novo Nordisk Inc | $1.31 | 06/22/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744749467 | CMS |
| Novo Nordisk Inc | $13.77 | 06/22/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744749471 | CMS |
| Amgen Inc. | $14.02 | 06/18/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 741074857 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.19 | 06/17/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 736295943 | CMS |
| Amarin Pharma Inc. | $10.82 | 06/16/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 739899731 | CMS |
| Novo Nordisk Inc | $14.14 | 06/08/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744746149 | CMS |
| SANOFI-AVENTIS U.S. LLC | $16.00 | 06/05/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744110899 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.62 | 06/04/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 735997517 | CMS |
| Amarin Pharma Inc. | $13.50 | 05/22/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 739896497 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.88 | 05/21/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 736164753 | CMS |
| Novo Nordisk Inc | $16.49 | 05/19/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744697233 | CMS |
| Zyla Life Sciences, Inc. | $13.45 | 05/16/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 749056707 | CMS |
| GlaxoSmithKline, LLC. | $23.07 | 05/15/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 738510415 | CMS |
| Amgen Inc. | $13.82 | 05/14/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 741074853 | CMS |
| GlaxoSmithKline, LLC. | $12.50 | 05/06/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 738509267 | CMS |
| Novo Nordisk Inc | $12.34 | 05/04/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744681781 | CMS |
| SANOFI-AVENTIS U.S. LLC | $11.72 | 04/24/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744110893 | CMS |
| Novo Nordisk Inc | $11.88 | 04/22/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744688319 | CMS |
| Novo Nordisk Inc | $16.83 | 04/07/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744659679 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.46 | 04/03/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 735902639 | CMS |
| Amarin Pharma Inc. | $19.31 | 03/27/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 739983891 | CMS |
| GlaxoSmithKline, LLC. | $12.50 | 03/12/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 738510079 | CMS |
| Novo Nordisk Inc | $14.71 | 03/10/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 744642235 | CMS |
| Amarin Pharma Inc. | $14.64 | 03/05/2020 | Food and Beverage | No dispute reported | Delay: No Change: UNCHANGED | 06/30/2026 | 739899735 | CMS |
By program year
All program years on this page · sorted by year
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.
Research Payments
One row per program year and role, newest year first · amounts for the two roles are never added together
| Program year | Role | Amount | Records |
|---|---|---|---|
| PY2025 | Principal investigator | $108,005.05 | 10 |
| PY2024 | Principal investigator | $63,829.74 | 8 |
| PY2023 | Principal investigator | $17,275.00 | 4 |
Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.
“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”
— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224
Research Payments records · PY2025
Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them
10 records in PY2025
| Role | Paying entity | Amount | Date | Recipient | Study | Dispute status | Published | Record ID |
|---|---|---|---|---|---|---|---|---|
| Principal investigator 1 | PFIZER INC. | $3,000.00 | 11/04/2025 | Non-covered Recipient Entity Alliance for Multispecialty Research LLC | AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 3 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS | No dispute reported | 06/30/2026 | 1228728561 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $12,588.00 | 10/24/2025 | Non-covered Recipient Entity ALLIANCE FOR MULTISPECIALTY RESEARCH | a phase third,randomised,double blind,placebo controlled,eventdriven study to evaluate the effect of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on the risk of incident heart failure and cardiovascular death in participants with increased risk of reveloping heart failure | No dispute reported | 06/30/2026 | 1185538627 |
| Principal investigator 1 | Ionis Pharmaceuticals, Inc. | $500.00 | 10/08/2025 | Non-covered Recipient Entity ALLIANCE FOR MULTISPECIALTY RESEARCH LLC | IS354CS9 | No dispute reported | 06/30/2026 | 1246788129 |
| Principal investigator 1 | Ionis Pharmaceuticals, Inc. | $575.00 | 10/08/2025 | Non-covered Recipient Entity ALLIANCE FOR MULTISPECIALTY RESEARCH LLC | IS354CS9 | No dispute reported | 06/30/2026 | 1246788133 |
| Principal investigator 1 | Ionis Pharmaceuticals, Inc. | $1,725.00 | 10/08/2025 | Non-covered Recipient Entity ALLIANCE FOR MULTISPECIALTY RESEARCH LLC | IS354CS9 | No dispute reported | 06/30/2026 | 1246788137 |
| Principal investigator 1 | Teva Pharmaceuticals USA, Inc. | $179.90 | 06/18/2025 | Non-covered Recipient Entity ALLIANCE FOR MULTISPECIALTY RESEARCH LLC | A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma | No dispute reported | 06/30/2026 | 1244048664 |
| Principal investigator 1 | AstraZeneca Pharmaceuticals LP | $5,900.00 | 06/06/2025 | Non-covered Recipient Entity ALLIANCE FOR MULTISPECIALTY RESEARCH | A Phase 3 Randomized Open label Study to Assess the Immunogenicity and Safety of IVX A12 when Co-administered with a licensed influenza vaccine | No dispute reported | 06/30/2026 | 1185538629 |
| Principal investigator 1 | PFIZER INC. | $5,000.00 | 02/14/2025 | Non-covered Recipient Entity Alliance for Multispecialty Research LLC | A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA IN HEALTHY INDIVIDUALS 18 THROUGH 64 YEARS OF AGE | No dispute reported | 06/30/2026 | 1228751080 |
| Principal investigator 1 | PFIZER INC. | $15,600.00 | 02/06/2025 | Non-covered Recipient Entity Alliance for Multispecialty Research LLC | AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 3 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS | No dispute reported | 06/30/2026 | 1228757316 |
| Principal investigator 1 | VERTEX PHARMACEUTICALS INCORPORATED | $62,937.15 | 01/01/2025 | Non-covered Recipient Entity AMR NASHVILLE TN | A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-design Study of the Efficacy and Safety of Suzetrigine in Subjects With Painful Diabetic Peripheral Neuropathy | No dispute reported | 06/30/2026 | 1214125206 |